DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dynacin (Minocycline Hydrochloride) - Side Effects and Adverse Reactions

 



ADVERSE REACTIONS

Due to oral minocycline's virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines.

Gastrointestinal: Anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, pancreatitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and increases in liver enzymes have been reported. Rarely, hepatitis and liver failure have been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Rare instances of esophagitis and esophageal ulcerations have been reported in patients taking the tetracycline-class antibiotics in capsule and tablet form. Most of these patients took the medication immediately before going to bed (see DOSAGE AND ADMINISTRATION).

Skin: Maculopapular and erythematous rashes. Exfoliative dermatitis has been reported but is uncommon. Fixed drug eruptions have been rarely reported. Lesions occurring on the glans penis have caused balanitis. Erythema multiforme and rarely Stevens-Johnson syndrome have been reported. Photosensitivity is discussed above (see WARNINGS). Pigmentation of the skin and mucous membranes has been reported.

Renal toxicity: Elevations in BUN have been reported and are apparently dose related (see WARNINGS). Acute renal failure has been rarely reported and, in most cases, has been reversible.

Hypersensitivity reactions: Urticaria, angioneurotic edema, polyarthralgia, anaphylaxis, anaphylactoid purpura, pericarditis, exacerbation of systemic lupus erythematosus and rarely pulmonary infiltrates with eosinophilia have been reported. A lupus-like syndrome and serum sickness-like reactions have also been reported.

Blood: Hemolytic anemia, thrombocytopenia, neutropenia, and eosinophilia have been reported.

Central nervous system: Bulging fontanels in infants and benign intracranial hypertension (pseudotumor cerebri) in adults (see PRECAUTIONS-General) have been reported. Headache has also been reported.

Other: When given over prolonged periods, tetracyclines have been reported to produce brown-black microscopic discoloration of the thyroid glands. Very rare cases of abnormal thyroid function have been reported.

Tooth discoloration in pediatric patients less than 8 years of age (see WARNINGS) and also, rarely, in adults have been reported.

Tinnitus and decreased hearing has been rarely reported in patients on minocycline hydrochloride.



REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO DYNACIN

Below is a sample of reports where side effects / adverse reactions may be related to Dynacin. The information is not vetted and should not be cosidered as verified clinical evidence.

Possible Dynacin side effects / adverse reactions in 32 year old female

Reported by a individual with unspecified qualification from United States on 2007-10-18

Patient: 32 year old female

Reactions: Drug Exposure During Pregnancy, Blighted Ovum, Abortion Spontaneous, Pregnancy

Suspect drug(s):
Dynacin
    Indication: Sweat Gland Infection
    End date: 2007-03-01

Rebif
    Dosage: 44 mcg/3 times wkly/sc
    Indication: Multiple Sclerosis
    Start date: 2006-03-14
    End date: 2007-03-01

Seroquel
    Indication: Insomnia
    End date: 2007-03-01

Relpax
    Dosage: prn
    Indication: Migraine
    End date: 2007-03-01

Celexa
    Indication: Depression
    End date: 2007-03-01

Provigil
    Indication: Fatigue
    End date: 2007-03-01

Vesicare
    Indication: Bladder Disorder
    End date: 2007-03-01

Baclofen
    Indication: Muscle Spasms
    End date: 2007-03-01



See index of all Dynacin side effect reports >>

Drug label data at the top of this Page last updated: 2006-06-23

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009